title: Insulin represses phosphoenolpyruvate carboxykinase gene transcription by causing the rapid disruption of an active transcription complex: a potential epigenetic effect.
abstract: Insulin represses gluconeogenesis, in part, by inhibiting the transcription of genes that encode rate-determining enzymes, such as phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G-6-Pase). Glucocorticoids stimulate expression of the PEPCK gene but the repressive action of insulin is dominant. Here, we show that treatment of H4IIE hepatoma cells with the synthetic glucocorticoid, dexamethasone (dex), induces the accumulation of glucocorticoid receptor, as well as many transcription factors, coregulators, and RNA polymerase II, on the PEPCK gene promoter. The addition of insulin to dex-treated cells causes the rapid dissociation of glucocorticoid receptor, polymerase II, and several key transcriptional regulators from the PEPCK gene promoter. These changes are temporally related to the reduced rate of PEPCK gene transcription. A similar disruption of the G-6-Pase gene transcription complex was observed. Additionally, insulin causes the rapid demethylation of arginine-17 on histone H3 of both genes. This rapid, insulin-induced, histone demethylation is temporally related to the disruption of the PEPCK and G-6-Pase gene transcription complex, and may be causally related to the mechanism by which insulin represses transcription of these genes.
authors.affiliation: Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, 707 Light Hall, Nashville, Tennessee 37232-0615, USA.
authors.forename: Robert K
authors.initials: RK
authors.lastname: Hall
authors.forename: Xiaohui L
authors.initials: XL
authors.lastname: Wang
authors.forename: Leena
authors.initials: L
authors.lastname: George
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Koch
authors.forename: Daryl K
authors.initials: DK
authors.lastname: Granner
mesh_terms: D000107:Acetylation; D000818:Animals; D045744:Cell Line, Tumor; D004257:DNA Polymerase II / Q000378:metabolism; D003907:Dexamethasone / Q000494:pharmacology; D044127:Epigenesis, Genetic; D005943:Gluconeogenesis; D005952:Glucose-6-Phosphatase / Q000235:genetics / Q000378:metabolism; D006657:Histones / Q000378:metabolism; D007328:Insulin / Q000502:physiology*; D008745:Methylation; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000235:genetics / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D051381:Rats; D011965:Receptors, Glucocorticoid / Q000378:metabolism; D014157:Transcription Factors / Q000378:metabolism*; D015533:Transcriptional Activation
chemical_list: D006657:Histones; D007328:Insulin; D011965:Receptors, Glucocorticoid; D014157:Transcription Factors; D003907:Dexamethasone; D004257:DNA Polymerase II; D005952:Glucose-6-Phosphatase; D010729:Phosphoenolpyruvate Carboxykinase (GTP)